Skip to content

Clinical trials

Observational Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Observational Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20171
20182
20194
20205
20211
20221
20233
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status7
Recruiting3
Terminated1
Active, not recruiting1
Withdrawn1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon2
Assistance Publique - Hôpitaux de Paris1
Beacon Biosignals1
Brigham and Women's Hospital1
Centre d'Investigation Clinique et Technologique 8051
Centro Hospitalar de Lisboa Central1
Chang Gung Memorial Hospital1
Guy's and St Thomas' NHS Foundation Trust1
Heinrich-Heine University, Duesseldorf1
I.M. Sechenov First Moscow State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence29
Sleep Apnea Syndromes6
Narcolepsy5
Sleep Apnea, Obstructive5
Sleep Initiation and Maintenance Disorders5
Sleep Wake Disorders4
Fatigue2
Idiopathic Hypersomnia2
Parasomnias2
Sleep Deprivation2

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.